Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The EMBO Journal
|
January 14, 2015
BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres
Sophie Badie, Ana Rita Carlos, Cecilia Folio, et al.
Journal of Proteome Research
|
June 5, 2009
Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets
Cecilia Folio, María I Mora, Marta Zalacain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
Ana Patiño-García, Marta Zalacain, Cecilia Folio, et al.
Cancer Biomarkers : Section a of Disease Markers
|
February 3, 2012
Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival
Cecilia Folio, Marta Zalacain, Carolina Zandueta, et al.
Nature Communications
|
October 29, 2013
ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
Ana Rita Carlos, Jose Miguel Escandell, Panagiotis Kotsantis, et al.
Molecular Cell
|
January 11, 2016
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds
Jutta Zimmer, Eliana M C Tacconi, Cecilia Folio, et al.
EMBO Molecular Medicine
|
July 22, 2017
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity
Eliana Mc Tacconi, Xianning Lai, Cecilia Folio, et al.
EMBO Molecular Medicine
|
July 6, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance
Eliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The EMBO Journal
|
January 14, 2015
BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres
Sophie Badie, Ana Rita Carlos, Cecilia Folio, et al.
Journal of Proteome Research
|
June 5, 2009
Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets
Cecilia Folio, María I Mora, Marta Zalacain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
Ana Patiño-García, Marta Zalacain, Cecilia Folio, et al.
Cancer Biomarkers : Section a of Disease Markers
|
February 3, 2012
Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival
Cecilia Folio, Marta Zalacain, Carolina Zandueta, et al.
Nature Communications
|
October 29, 2013
ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
Ana Rita Carlos, Jose Miguel Escandell, Panagiotis Kotsantis, et al.
Molecular Cell
|
January 11, 2016
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds
Jutta Zimmer, Eliana M C Tacconi, Cecilia Folio, et al.
EMBO Molecular Medicine
|
July 22, 2017
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity
Eliana Mc Tacconi, Xianning Lai, Cecilia Folio, et al.
EMBO Molecular Medicine
|
July 6, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance
Eliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis, et al.
Page
of 1